Delivery Order SPE2DB20D1004-SPE2DB22FF9X0
- Not listed
- This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S to the Defense Logistics Agency (DLA). The $9,188.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. doing business as Amerisourcebergen. The contract has an ultimate completion date of March 13, 2024 and was awarded on March 12, 2024. There was no set-aside designation used for this award. Amerisourcebergen holds a significant...
- This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S to the Defense Logistics Agency (DLA). The contract, valued at $9,616.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and is set to be completed by February 6, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award is for the delivery of JANUMET 50-500 MG TABLET 180S to the Defense Logistics Agency (DLA), a defense agency. The $1,646.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 16, 2024, with an ultimate completion date of January 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,208.83 firm-fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2024 and was awarded on February 9, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of JANUMET 50-500 MG TABLET 180S to the Defense Logistics Agency (DLA). The $3,854.98 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2023. The contract has an ultimate completion date of November 24, 2023 and is a firm fixed-price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,422.04 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S to the Defense Logistics Agency (DLA), a defense agency. The $6,037.65 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 1, 2024, with a completion date of May 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,572.13 for the supply of JANUMET 50-1,000 MG TABLET 60S to the Defense Logistics Agency (DLA). The award has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
- This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,316.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 9, 2023. The contract has a completion date of February 10, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a total ceiling value of $6,386.29 and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF9X0Delivery Order
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S pharmaceutical products to the Defense Logistics Agency (DLA). The $7,080.54 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 2, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical and medical supplies to the Department of Defense and other federal healthcare programs. This task order award is not designated as a set-aside contract. The contract supports the DLA's mission to efficiently procure essential medical commodities for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 8/1/22 |